Working... Menu

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00951535
Recruitment Status : Active, not recruiting
First Posted : August 4, 2009
Last Update Posted : July 24, 2018
Information provided by (Responsible Party):
Cancer Trials Ireland

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : July 2016
  Estimated Study Completion Date : September 2026